Navigation Links
FDA Examines Ways to Improve Consumer Understanding of Prescription Drug Ads

SILVER SPRING, Md., June 20, 2011 /PRNewswire-USNewswire/ -- Findings from three studies conducted by the U.S. Food and Drug Administration confirm that the way information is conveyed and displayed in printed drug advertising affects consumer understanding of prescription medications.


The studies, designed by experts in FDA's Division of Drug, Marketing, Advertising and Communications (DDMAC) in the Center for Drug Evaluation and Research, examined ways to improve understanding of how consumers use the "brief summary" section of printed prescription drug ads.

The online edition of the journal "Medical Decision Making" published findings from the third study today.

The Federal Food, Drug, and Cosmetic Act specifies that print advertisements for prescription drugs and biological products are required to provide a true statement of information "in brief summary" about the advertised product's "side effects, contraindications, and effectiveness."  

"Some of the current approaches to fulfilling the brief summary requirement, while adequate from a regulatory perspective, are not optimal in communicating this important information to consumers," said Thomas Abrams, director of DDMAC. "FDA's research and policy development seeks to improve the presentation of this information so it is easier for consumers to read and understand."

Print ads for prescription drugs are often two (or more) pages long. The first page of the prescription drug ad may feature a picture, information about what the product is intended to be used for, and important information about the product's risks. The second page summarizes all the product's risks and may be presented as densely-packed text information.

In the first study, a serious risk was added to the first and second page of the ad.  In the second study, additional information about side effects was included on the second page.  The third study tested four different brief summary formats:

Traditional (block text paragraphs), Question and Answer (with headings framed in the form of questions), Highlights (based on the highlights section of the physician labeling), and Prescription Drug Facts Box (resembling the current Over the Counter Drug Facts label).

Key findings of the studies include:

  • Adding a serious risk did not hinder people's understanding of the risk information.
  • Including additional information about how often side effects occur and how long they may last did not hinder people's understanding of the risk information.
  • Participants who viewed the Drug Facts format were better able to recall risks than those who saw the traditional format.

FDA researchers Kathryn Aikin, Ph.D., Amie O'Donoghue, Ph.D., and Helen Sullivan, Ph.D., M.P.H., and Jack Swasy, Ph.D., from American University designed and led the three experimental studies.

A copy of "Randomized Trial of Risk Information Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs" will be available in the September/October 2011 issue of "Medical Decision Making."

For more information:

Randomized Trial of Risk Information Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs

Background on Prescription Drug Advertising

Division of Drug Marketing, Advertising and Communication (DDMAC) Research  

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Shelly Burgess, 301-796-4651,
Consumer Inquiries: 888-INFO-FDA

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AAHC Examines Nations Clinical Trials Infrastructure
2. New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
3. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
4. Turning the Page in HIV Prevention Research: An AIDS Vaccine is Possible — AVAC Examines The Way Forward
5. New Report by BioTrends Examines the Treatment of Renal Anemia in China
6. New Second Edition of Pharmaceutical Patent Law Examines Critical Intersection of Patent Law and Food and Drug Law
7. New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
8. UL White Paper Examines Key Implications of Growing Home Healthcare Industry
9. FDLIs Food and Drug Policy Forum Examines European GMO Rules
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  "They really did ... of her Kaiser Permanente care team, after a routine ... treatment plan for cancer. The 79-year-old Kaiser Permanente Senior ... , went in for what she thought was tendinitis ... physician and care team, however, she was diagnosed with ...
(Date:10/8/2015)...  Trovagene, Inc., (NASDAQ:   TROV) a developer ... of results from a field experience analysis featuring ... (PCM) platform to accurately identify mutational status, ... appropriate therapy for patients. Mark Erlander , ... the results today in an oral presentation titled ...
(Date:10/8/2015)... York , October 8, 2015 ... Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 ... valued at USD 2.63 billion in 2013 and is anticipated ... 2022 to reach USD 4.00 billion in 2022. --> ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - ...
Breaking Medicine Technology:
... Calif., May 17, 2012   Accuray Incorporated (Nasdaq: ... announced today the appointment of Richard Pettingill, LFACHE as ... May 11, 2012.   Richard Pettingill,s career ... leadership positions in a variety of prominent organizations. Most ...
... 2012 Simbionix USA Corporation, the ... education products, is proud to announce the release ... GI Mentor™ Express simulator and the ...      (Logo: ...
Cached Medicine Technology:
(Date:10/9/2015)... ... ... For many, October is a month whose focus has long been on ... cure. At Beverly Hills Physicians in Southern California, it is also a time to ... Beverly Hills Physicians is encouraging patients and non-patients alike to donate their new and ...
(Date:10/9/2015)... Nashville, TN (PRWEB) , ... October 09, 2015 ... ... one of three best audiologists in The Tennessean's eighth annual Toast of Music ... play. , Local Nashville residents nominated and cast votes for their favorite ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy Foundation of America ... Control and Prevention (CDC) to improve the knowledge and skills of underserved adults with ... a project by the CDC and allows AAFA to continue vital efforts to educate ...
(Date:10/9/2015)... Australia (PRWEB) , ... October 09, 2015 , ... ... in an upcoming episode of Innovations with Ed Begley Jr., airing 1st QT ... segment, Innovations will educate audiences on MMJ Phytotech Limited (MMJ) – a global ...
(Date:10/9/2015)... Maryland (PRWEB) , ... October 09, 2015 , ... ... and assisted living placement counseling, recently opened its newest office in Maryland – ... senior care industry with a background as a project management technology consultant to ...
Breaking Medicine News(10 mins):
... ... identification methods produce inaccurate results; relationship models are more effective than bibliometric lists in ... ... generally-held notion that scientists who are “productive” in terms of publishing are well connected ...
... , CHICAGO , Jan. 28 Code ... Express, Inc., a portfolio investment of CHS Private Equity V ... New York -based private equity firm.   , Suture Express ... medical and surgical products.  Suture Express offers over 1,600 acute ...
... known that smokers damage their health by directly inhaling ... access journal Environmental Health has shown that ... smoke, contrary to the prevailing assumption that such risks ... actually smoking. Maria Teresa Piccardo worked with a ...
... ... ... -- Celebrity doctors attract high-value patients, get book deals, CNN expert spots, lucrative speaking engagements, ... and branding experts report high-visibility doctors are as adept at publicity and personal branding as ...
... Jan. 28 Grubb & Ellis Healthcare REIT II, ... to acquire Highlands Ranch Medical Pavilion, an approximately 37,000-square-foot, multi-tenant ... Highlands Ranch .  The acquisition is subject to customary ... in the agreement.   , Located at 8671 S. Quebec ...
... YORK , Jan. 28 Care Investment Trust Inc. ... estate investment and finance company formed to invest in healthcare-related real ... Liquidation (the "Plan"), previously approved by the Company,s Board of Directors ... at a special meeting called for that purpose.  Approval of the ...
Cached Medicine News:
... latest addition to our suite ... is the personal-sized GeneAmp PCR ... for both basic PCR and ... the culmination of several years ...
... 96 well thermocycler with ... Peltier technology for fastest available ... to 4C/sec with High Pressure ... PCR plates. Includes motorized ...
... highest precision, more user-friendliness and absolute reliability ... the definition of the Mastercycler ep system. ... research has been developing dynamically. The same ... Systems. To keep pace with these ...
... The Techne TC412 is a high performance, ... price. Features & Benefits include: Flexible ... intuituve programming, 8 peltiers, PC networking. Includes ... Up to 32 Techne cyclers can be connected ...
Medicine Products: